KPTI

Karyopharm Therapeutics (KPTI)

About Karyopharm Therapeutics (KPTI)

Karyopharm Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company was founded by Joseph Araujo, Ronald A. DePinho, Pamela A. Silver, Giulio Draetta, Michael G. Kauffman, and Sharon Shacham on December 22, 2008 and is headquartered in Newton, MA.

Details

Daily high

$9.51

Daily low

$8.82

Price at open

$8.89

52 Week High

$10.99

52 Week Low

$3.65

Market cap

204.0M

Dividend yield

0.00%

Volume

188,806

Avg. volume

359,002

P/E ratio

-.60

Karyopharm Therapeutics News